-- New Phase 3 trial of Genasense(R) seeks to confirm benefit in melanoma BERKELEY HEIGHTS, N.J., Aug. 7 /PRNewswire-FirstCall/ -- Genta...
BERKELEY HEIGHTS, N.J., Aug. 2 /PRNewswire-FirstCall/ -- Genta Incorporated (NASDAQ:GNTAD) announced that the Company will release its second...
BERKELEY HEIGHTS, N.J., July 30 /PRNewswire-FirstCall/ -- Genta Incorporated (NASDAQ:GNTAD) announced today that the Company has been formally...
AGENDA Trial Set to Confirm Findings in Marketing Application BERKELEY HEIGHTS, N.J., July 19 /PRNewswire-FirstCall/ -- Genta Incorporated...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.